Abstract
Mucormycosis of the anterior abdominal wall is an uncommon disease and it is very rare to find this disease in immunocompetent, non-diabetic patients which usually affects patients with trauma, with contaminated wounds, patients with underlying malignancies or patients with immunocompromised state, e.g., diabetics. We herein report a case of primary cutaneous mucormycosis in an immunocompetent and non-diabetic patient. Our patient was a 48-year-old female, executive by profession. She was diagnosed to have cutaneous mucormycosis of the anterior abdominal wall, and was managed with multiple debridements of the wound and intravenous amphotericin B therapy. She was administered a total of 1500 mg of liposomal amphotericin B and when fully healed, split skin grafting was done. We would like to emphasize the importance of high index of suspicion and early start of therapy in a condition with high rate of mortality.
Similar content being viewed by others
References
Paltauf A (1885) Mucormycosis mucorina. Virchows Arch Pathol Anat 102:543–564
Gilbard SM, Della Rocca RC (1998) Paranasal sinus disease and the orbit. In Nesi FA, et al., (Ed.), Smith’s Ophthalmic Plastic and Reconstructive Surgery. 2nd edition. CV Mosby, St. Louis, MO 896–930
Alan MS (2005) Agents of mucormycosis & related species. In Gerald LM, John EB, Raphael D, (Eds.). Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 6th edition. Churchill Livingstone, Philadelphia 2973–2984
Wani Tehmeena, Wajahat Hussain, Haroon R Zargar, Abdul Rashid Sheikh, Shabir Iqbal (2007) Primary cutaneous mucormycosis in an immunocompetent host. Mycopathologia 164:197–199
Arvind Kumar, Gopi C Khilnani, Sandeep Aggarwal, Subodh Kumar, Uma Banerjee, Immaculata Xess (2003) Primary Cutaneous Mucormycosis in an Immunocompetent host. Surg Today 33:319–322
Goodman NL, Rinaldi MG (1991) Agents of zygomycosis. In Balows A, Hausler WJ, et al. (Eds.), Manual of clinical microbiology, 5th edition, Washington DC: American Society for Microbiology, 674–692
Kwon-Chung KJ, Bennett JW (1992) Medical Mycology. Philadelphia Lea & Febiger
Baraia J, Munoz P, et al. (1995) Cutaneous mucormycosis in a heart transplant patient associated with a peripheral catheter. Eur J Clin Microbiol Infect Dis 14:813–815
Leong KW, Crowley B, et al. (1997) Cutaneous mucormycosis due to Absidia corymbifera occurring after bone marrow transplantation. Bone Marrow Transplant 19:513–515
Gartenberg G, Bottone EJ et al. (1978) Hospital acquired mucormycosis (Rhizopus rhizopodiformis) of skin and subcutaneous tissue. N Engl J Med 299:1115–1118
Ng TC, Denning DW (1995) Liposomal Amphotericin B (AmBisome) therapy in invasive fungal infections. Arch Intern Med 155:1093–1098
Greenberg RN, Scott LJ, Vaughn HH, Ribes JA (2004) Zygomycosis (mucormycosis): Emerging clinical importance and new treatments. Curr Opin Infect Dis 17:517–525
Mileshkin L, Slavin M, Seymour JF, Mckenzie A (2001) Successful treatment of rhinocerebral zygomycosis using liposomal nystatin. Leuk Lymph 42:1119–1123
Spellberg B, Edwards J Jr, Ibrahim A (2005) Novel perspectives on mucormycosis: Pathophysiology, presentation and management. Clin Microbial Rev 18:556–569
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tapish, S., Taha, M., Naresh, G. et al. Primary mucormycosis of abdominal wall: A rare fungal infection in a immunocompetent patient. Indian J Surg 72 (Suppl 1), 306–308 (2010). https://doi.org/10.1007/s12262-010-0080-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12262-010-0080-x